Recent

% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

insidetrack22 3 posts  |  Last Activity: Jul 5, 2016 10:22 AM Member since: Jun 3, 2002
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • insidetrack22 by insidetrack22 Jun 15, 2016 1:01 PM Flag

    IMGN management have no ownership in IMGN and uses IMGN as an ATM (withdrawals only). Historical chart shows you each time IMGN gains traction, shareholders value gets diluted with new stocks being issues and in this case new notes issued (IOUs). IMGN management have milked investors capital with false hopes of developing their own drug while their only source of revenue stream is paltry royalties. With the current stock price around $3 and earnings per share -$2, IMGN management have pretty much milked IMGN to the ground. IMGN CEO should be whipped and thrown out of management. If you enjoy making a donation to support extravagant life styles of CEOs, IMGN is for you.

  • insidetrack22 by insidetrack22 Jun 24, 2016 2:38 PM Flag

    (1) Terrible Earnings: CLVS existence is off of investor's money. With an negative $10 earnings on a $13 per share price tag, CLVS is burning through investor's cash at an astronomical rate
    (2) Putting all your eggs in one basket is bad strategy- CLVS have only one (yes..one) viable product in the pipeline. If FDA rejects, it's either Chapter 11 or major stock dilution. Risk does not justify benefit
    (3) No near term catalyst- No partnerships in sight, no FDA approval in site, no acquisitions in site. It's like a sail boat with no wind. Dead in the water while burning through cash.
    (4) Smart money is exiting- Net change within the last quarter in institutional held shares is -20%. If the big boys are heading toward the exit in an orderly fashion, why I am entering a burning building? Even management is not holding on to their shares with dumping 34K shares last quarter.
    (5) CLVS was basically a fly on the wall at ASCO. That's pretty bad.

    Not sure what I was thinking when I bought CLVS....... possibly irrational Greed.

  • Reply to

    Management has house in order.

    by cagyest Jun 29, 2016 1:36 PM
    insidetrack22 insidetrack22 Jul 5, 2016 10:22 AM Flag

    cagiest:
    Did you see GHL's balance sheet, income statement (especially interest on debt and debt versus revenue??)
    GHL's problems has nothing to do with Brexit. It has to do with poor management of debt with shrinking revenue and margins. CFO needs to wake up. Also, dividends are based on the stock price. Of course dividends will survive since during the last 3 weeks GHL price dropped 20%.

IMGN
2.79-0.13(-4.45%)Jul 28 4:00 PMEDT